Clinical Trials Directory

Trials / Unknown

UnknownNCT05090917

Growth Curves in Cockayne Syndrome Type 1 and Type 2

Development of Growth Curves in Cockayne Syndrome Type 1 and Type 2

Status
Unknown
Phase
Study type
Observational
Enrollment
85 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
1 Year – 17 Years
Healthy volunteers
Not accepted

Summary

Despite the natural progression of Cockayne's syndrome, affected patients also present with variable neurological and gastrointestinal damage (gastroesophageal reflux, recurrent vomiting, swallowing disorders, etc.) with varying repercussions on their growth. Acute intercurrent events such as seizures, constipation, infections can also interact with their metabolism, food intake and influence their growth. The nutritional deficit potentially involved in this growth retardation can be responsible for many manifestations such as anemia, bone fractures, fatigue, coagulation disorders responsible in total for the reduction in quality and life expectancy. Faced with growth retardation in patients with Cockayne syndrome, medical management is difficult to establish. Is this delay part of the natural course of the pathology?

Conditions

Timeline

Start date
2020-11-01
Primary completion
2022-05-15
Completion
2022-05-15
First posted
2021-10-25
Last updated
2021-12-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05090917. Inclusion in this directory is not an endorsement.